RxDoctor Payments Data

Scott Roos, MD

Family Medicine · Lake St Louis, MONPI 1770596983

Payments from drug & device makers

$5,764in general payments, 2019–2025

Across 359 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$784
  • Novo Nordisk$666
  • AstraZeneca$537
  • Pfizer$458
  • GSK$408
  • Takeda Pharmaceuticals U.S.A., Inc.$230
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$5,764100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,764 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$121,249
Medicare patients
277
Services billed
2,047

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$101,396
EliquisApixaban85$96,895
JardianceEmpagliflozin55$76,178
MounjaroTirzepatide33$54,607
FarxigaDapagliflozin Propanediol38$46,082
TradjentaLinagliptin48$44,827
XareltoRivaroxaban27$37,374
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$31,073
MyrbetriqMirabegron37$26,253
RybelsusSemaglutide13$25,222
TrulicityDulaglutide11$17,490
TrintellixVortioxetine Hydrobromide20$15,697
LinzessLinaclotide11$8,203
Breo ElliptaFluticasone/Vilanterol15$7,582
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$7,354

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$666$126,61860 claims
Boehringer IngelheimJardiance, Tradjenta$158$121,005103 claims
PfizerEliquis, Abrysvo$458$100,51198 claims
Lilly USA, LLCMounjaro, Trulicity$226$72,09644 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arexvy$408$52,11188 claims
AstraZenecaFarxiga$537$46,08238 claims
Johnson & JohnsonXarelto$143$37,37427 claims
Astellas Pharma US IncMyrbetriq$224$26,25337 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$230$15,69720 claims
AbbVieLinzess, Synthroid$784$10,42557 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Lake St Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →